The company's asset base has eroded from $4.4 billion in 2024Q1 to $3.4 billion in 2026Q1, reflecting a structural contraction in resources despite maintaining a debt-to-equity ratio of 0.00.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 |
|---|
| Total Current Assets | 3.06B | 3.08B | 3.34B | 3.86B | 4.24B | 4.86B | 5.37B | 5.87B | 1.33B | 1.2B | 1.01B | 374.47M | 213.6M | 173.35M | 132.73M | 65.56M | 109.22M | 84.69M | 59.85M | 80.74M | 79.86M | 36.55M | 12.54M |
| Cash & Short-Term Investments | 2.98B | 3B | 3.12B | 3.68B | 4.09B | 4.7B | 5.16B | 5.78B | 1.29B | 1.15B | 973.24M | 340.31M | 187.71M | 138.18M | 94.65M | 32.55M | 40.4M | 47.39M | 27.32M | 49.3M | 51.52M | 23.62M | 10.27M |
| Cash Only | 66.81M | 87.83M | 64.24M | 166.8M | 508.12M | 2.23B | 2.14B | 1.86B | 1.29B | 1.15B | 973.24M | 340.31M | 187.71M | 138.18M | 94.65M | 32.55M | 40.4M | 47.39M | 27.32M | 49.3M | 51.52M | 23.62M | 10.27M |
| Short-Term Investments | 2.92B | 2.91B | 3.05B | 3.52B | 3.59B | 2.47B | 3.03B | 3.92B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 54.03M | 53.2M | 47.48M | 65.66M | 77.34M | 128.6M | 173.4M | 80.11M | 33.53M | 41.79M | 23.48M | 16.06M | 13.79M | 31.98M | 33.24M | 28.86M | 63.48M | 31.98M | 26.62M | 22.08M | 24.85M | 9.79M | 2.17M |
| Days Sales Outstanding | 25.03 | 17.46 | 62.87 | 99.97 | 117.02 | 96.81 | 132.39 | 35.02 | 42.38 | 120.02 | 66.16 | 148.14 | 72.59 | 84.77 | 89.04 | 109.85 | 189.3 | 125.41 | 126.2 | 122.22 | 258 | 317.78 | 101.8 |
| Inventory | 17.69M | 0 | 51.19M | 73.98M | 52.92M | 20.57M | 355K | 255K | 276K | 279K | 300K | 325K | 281K | 249K | 204K | 502K | 1.44M | 1.82M | 3.57M | 4.95M | 3.5M | 3.14M | 98K |
| Days Inventory Outstanding | 442.72 | - | 535.96 | - | - | 4.61K | 0.25 | 0.22 | 0.31 | 0.47 | 0.78 | 0.91 | 0.92 | 2.2 | 1.55 | 1.47 | 4.52 | 7.79 | 46.98 | 59.87 | 65.38 | 237.49 | 27.77 |
| Other Current Assets | 6.77M | 28.17M | 123.11M | 36.72M | 12.03M | 9.3M | 33.91M | 4.44M | 4.1M | 3.83M | 10.19M | 17.76M | 11.81M | 820K | 2.51M | 877K | 3.9M | 3.5M | 2.34M | 4.42M | 0 | 0 | 0 |
| Total Non-Current Assets | 311.69M | 326.92M | 796.27M | 495.81M | 497.5M | 331.31M | 348.38M | 202.68M | 110.64M | 88.63M | 76.11M | 68.04M | 56.86M | 114.03M | 102.6M | 95.49M | 84.74M | 59.02M | 58.98M | 67.98M | 87.78M | 45.02M | 3.07M |
| Property, Plant & Equipment | 76.95M | 0 | 122.9M | 126.32M | 154.25M | 137.51M | 103.38M | 66.05M | 23.14M | 16.69M | 14.96M | 13.78M | 10.09M | 19.52M | 18.1M | 19.52M | 23.89M | 19.29M | 20.29M | 22.91M | 25.96M | 9.4M | 2.63M |
| Fixed Asset Turnover | 10.67x | - | 2.24x | 1.90x | 1.56x | 3.53x | 4.62x | 12.64x | 12.48x | 7.61x | 8.66x | 2.87x | 6.87x | 7.05x | 7.53x | 4.91x | 5.12x | 4.83x | 3.79x | 2.88x | 1.35x | 1.20x | 2.96x |
| Goodwill | 0 | 0 | 70.01M | 69.56M | 69.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.24M | 37.67M | 38.88M | 42.38M | 33.75M | 33.75M | 33.95M | 35.56M | 29.48M | 0 |
| Intangible Assets | 746K | 847.64K | 164.86M | 127.91M | 146.35M | 60.1M | 67.57M | 24.93M | 3.63M | 2.5M | 1.02M | 1.55M | 2.02M | 7.83M | 9.43M | 10.62M | 13.53M | 3.48M | 4.16M | 6.09M | 17.84M | 4.87M | 447K |
| Long-Term Investments | 416.06M | 221.13M | 253.12M | 13.57M | 0 | 0 | 8.95M | 11.28M | 6M | 1.75M | 0 | 0 | 0 | 220K | 0 | 1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 185.9M | 104.95M | 183.9M | 157.32M | 125.72M | 129.66M | 164.01M | 96.22M | 75.36M | 65.7M | 58.17M | 50.98M | 44.46M | 42.65M | 35.7M | 23.27M | 1.28M | 807K | 772K | 4.67M | 7.68M | 1.27M | 0 |
| Total Assets | 3.37B | 3.41B | 4.14B | 4.36B | 4.73B | 5.19B | 5.72B | 6.07B | 1.44B | 1.29B | 1.08B | 442.51M | 270.47M | 287.37M | 235.33M | 161.06M | 193.96M | 143.71M | 118.82M | 148.72M | 167.65M | 81.56M | 15.61M |
| Asset Turnover | 0.28x | 0.33x | 0.07x | 0.06x | 0.05x | 0.09x | 0.08x | 0.14x | 0.20x | 0.10x | 0.12x | 0.09x | 0.26x | 0.48x | 0.58x | 0.60x | 0.63x | 0.65x | 0.65x | 0.44x | 0.21x | 0.14x | 0.50x |
| Asset Growth % | -45.88% | -17.67% | -5.09% | -7.96% | -8.83% | -9.17% | -5.78% | 321.58% | 11.91% | 18.73% | 144.81% | 63.61% | -5.88% | 22.12% | 46.12% | -16.97% | 34.97% | 20.94% | -20.1% | -11.29% | 105.54% | 422.4% | - |
| Total Current Liabilities | 100.42M | 152.8M | 335.08M | 428.22M | 522.54M | 566.47M | 635.27M | 571.79M | 219.91M | 171.7M | 103.79M | 72.41M | 60.36M | 112.56M | 109.01M | 35.36M | 38.22M | 31.34M | 29.75M | 43.36M | 29.28M | 14.06M | 3.61M |
| Accounts Payable | 95.77M | 104.6M | 97.78M | 134.65M | 133.3M | 134.3M | 171.32M | 142.51M | 68.04M | 47.12M | 31.21M | 29.11M | 29.34M | 29.36M | 22.09M | 18.07M | 22.01M | 15.13M | 13.43M | 13.29M | 25.43M | 9.57M | 2.77M |
| Days Payables Outstanding | 1.67K | 1.28K | 1.02K | - | - | 30.09K | 119.41 | 123.82 | 76.91 | 78.72 | 81.61 | 81.92 | 96.4 | 259.53 | 167.38 | 52.76 | 69.25 | 64.9 | 176.46 | 160.84 | 475.21 | 723.2 | 783.84 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16K | 0 | 0 | 394K | 0 |
| Deferred Revenue (Current) | 500.69M | 0 | 0 | 256.27M | 365.63M | 419.87M | 443.16M | 414.3M | 149.8M | 122.54M | 70.83M | 39.81M | 27.03M | 78.98M | 83.61M | 13.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.13M | 45.51M | 232.72M | 32.04M | 8.51M | 204K | 12.08M | 6.2M | 1K | 0 | 60K | 368K | 767K | 81K | 177K | 394K | 15.79M | 15.65M | 15.72M | 27.39M | 556K | 0 | 842K |
| Current Ratio | 30.48x | 20.15x | 9.97x | 9.02x | 8.11x | 8.58x | 8.45x | 10.26x | 6.04x | 6.98x | 9.70x | 5.17x | 3.54x | 1.54x | 1.22x | 1.85x | 2.86x | 2.70x | 2.01x | 1.86x | 2.73x | 2.60x | 3.48x |
| Quick Ratio | 30.30x | 20.15x | 9.81x | 8.84x | 8.01x | 8.55x | 8.45x | 10.26x | 6.04x | 6.97x | 9.70x | 5.17x | 3.53x | 1.54x | 1.22x | 1.84x | 2.82x | 2.64x | 1.89x | 1.75x | 2.61x | 2.37x | 3.45x |
| Cash Conversion Cycle | -1.2K | - | -424.89 | - | - | -25.39K | 13.23 | -88.58 | -34.23 | 41.77 | -14.67 | 67.13 | -22.89 | -172.57 | -76.79 | 58.55 | 124.56 | 68.3 | -3.28 | 21.25 | -151.83 | -167.93 | -654.27 |
| Total Non-Current Liabilities | 18.64M | 17.78M | 903.7M | 1.13B | 1.69B | 1.98B | 2.41B | 2.62B | 5.34M | 102.59M | 220.85M | 5.1M | 3.98M | 7.68M | 7.87M | 7.32M | 7.23M | 3.49M | 4.75M | 6.74M | 28.83M | 6.36M | 1.64M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 22.86M | 5.18M | 8.24M | 4.94M | 14.69M | 19.66M | 23.04M | 19.56M | 0 | 0 | 9K | 63K | 115K | 167K | 165K | 451K | 867K | 964K | 1.16M | 1.75M | 4.59M | 4.61M | 0 |
| Deferred Tax Liabilities | 17.88M | 0 | 20.66M | 23.61M | 20.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.19M | 2.62M | 2.4M | 2.69M | 564K | 201K | 292K | 594K | 1.54M | 225K |
| Other Non-Current Liabilities | 13.79M | 12.6M | 35.92M | 33.86M | 27.35M | 18.83M | 23.09M | 15.25M | 5.34M | 5.24M | 6.05M | 5.04M | 3.86M | 5.32M | 5.08M | 4.46M | 3.67M | 1.96M | 3.39M | 4.7M | 23.64M | 214K | 1.41M |
| Total Liabilities | 119.06M | 170.58M | 1.24B | 1.56B | 2.21B | 2.55B | 3.05B | 3.19B | 225.25M | 274.29M | 324.64M | 77.52M | 64.33M | 120.24M | 116.88M | 42.68M | 45.45M | 34.83M | 34.5M | 50.1M | 58.1M | 20.43M | 5.25M |
| Total Debt | 6.43M | 6.92M | 11.72M | 9.6M | 21.9M | 26.86M | 29.44M | 25.38M | 0 | 9K | 63K | 115K | 167K | 393K | 405K | 876K | 1.25M | 1.48M | 1.7M | 4.37M | 7.77M | 7.97M | 0 |
| Net Debt | -60.37M | -80.92M | -52.52M | -157.21M | -486.22M | -2.21B | -2.11B | -1.84B | -1.29B | -1.15B | -973.18M | -340.2M | -187.54M | -137.78M | -94.24M | -31.68M | -39.15M | -45.91M | -25.61M | -44.93M | -43.75M | -15.65M | -10.27M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.02x | 0.04x | 0.07x | 0.13x | - |
| Debt / EBITDA | 0.04x | 0.01x | - | - | - | - | - | 0.07x | - | - | - | - | - | - | 0.17x | - | 0.10x | 0.17x | - | - | - | - | - |
| Net Debt / EBITDA | -0.38x | -0.15x | - | - | - | - | - | -4.91x | - | - | - | - | - | - | -39.28x | - | -3.09x | -5.33x | - | - | - | - | - |
| Interest Coverage | 8.41x | 136.71x | -2.39x | 4.47x | -6.74x | -10.54x | -15.42x | 199.92x | -39.28x | -122.40x | -244.47x | -472.97x | -319.01x | -101.78x | -33.35x | -20.34x | 1.38x | 3.37x | -1.80x | -12.43x | -10.82x | -17.02x | -21.02x |
| Total Equity | 3.25B | 3.23B | 2.9B | 2.8B | 2.53B | 2.64B | 2.67B | 2.88B | 1.21B | 1.01B | 758.7M | 365M | 206.13M | 167.14M | 118.45M | 118.38M | 148.51M | 108.88M | 84.32M | 98.63M | 109.54M | 61.14M | 10.37M |
| Equity Growth % | 21.38% | 11.65% | 3.63% | 10.67% | -4.44% | -1.01% | -7.14% | 136.83% | 19.99% | 33.38% | 107.86% | 77.07% | 23.33% | 41.11% | 0.06% | -20.29% | 36.4% | 29.12% | -14.5% | -9.97% | 79.18% | 489.72% | - |
| Book Value per Share | 49.39 | 49.09 | 43.80 | 42.40 | 38.45 | 40.36 | 41.04 | 49.91 | 23.30 | 20.45 | 16.60 | 10.22 | 6.85 | 5.81 | 4.46 | 4.48 | 6.12 | 5.03 | 3.98 | 4.77 | 8.09 | 6.84 | 1.75 |
| Total Shareholders' Equity | 3.25B | 3.23B | 2.9B | 2.8B | 2.53B | 2.64B | 2.67B | 2.88B | 1.21B | 1.01B | 758.7M | 365M | 206.13M | 167.14M | 118.45M | 118.38M | 148.51M | 108.88M | 84.32M | 98.63M | 109.54M | 61.14M | 10.37M |
| Common Stock | 293.94M | 293.81M | 293.94M | 293.94M | 293.6M | 292.07M | 291.31M | 287.28M | 236.54M | 233.41M | 223.93M | 185.4M | 157.27M | 154.54M | 139.35M | 137.46M | 137.12M | 122.87M | 110.86M | 110.86M | 104.4M | 69.05M | 31.56M |
| Retained Earnings | 228.33M | 210.49M | -134.31M | -228.27M | -496.69M | -367.2M | -334.7M | -109.22M | -297.78M | -211.44M | -112.27M | -177.32M | -63.94M | -100.11M | -94.77M | -91.14M | -60.08M | -66.87M | -72.49M | -58.96M | -39.03M | -27.73M | -21.19M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -5.89M | 3M | 314K | -7.09M | -6.45M | -11.9M | -14.1M | -5.98M | -2.29M | -3.01M | -2.09M | -485K | -1.38M | 217K | 994K | 35K | 71.46M | 52.88M | 45.96M | 46.73M | 44.18M | 19.82M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Rapid liquidity depletion
As reported in financial statements, Galapagos's total assets declined from $4.4 billion in 2024Q1 to $3.4 billion by 2026Q1, reflecting a structural contraction in the company's resource base as it pivots away from commercial inflammation assets toward a more speculative, early-stage oncology-focused research model.
The consistent decline in total assets suggests that the company is consuming its historical capital base to fund ongoing operations rather than replacing it through organic growth or successful commercialization. This trajectory warrants investor caution, as the shrinking asset base limits the company's future strategic flexibility and potential for long-term value creation.
Based on recent quarterly filings, the company's cash position plummeted to $66.8 million in 2026Q1 from a peak of $166.8 million in 2023Q4, indicating a rapid depletion of liquid reserves that may leave the firm with insufficient runway to sustain its current high-burn R&D initiatives.
While the current ratio remains mathematically elevated due to the accounting treatment of deferred revenue, the actual cash-on-hand is insufficient to support the company's historical operating expenses. This discrepancy suggests that the headline liquidity metrics may be misleading, and the firm may face imminent pressure to secure additional financing.
According to the provided balance sheet data, retained earnings have shifted from a negative $228.3 million in 2023Q4 to a positive $228.3 million in 2026Q1, a swing that appears driven by accounting adjustments rather than sustained operational profitability or the accumulation of organic earnings.
The volatility in equity quality highlights the reliance on non-recurring collaboration milestones to bolster the balance sheet. Investors should monitor whether this equity base can remain stable without further reliance on external partnership capital, as the current structure appears highly sensitive to accounting-driven fluctuations.
As indicated by the company's financial disclosures, the presence of significant deferred revenue, which peaked at $1.3 billion in 2023Q4, creates a misleading impression of financial stability by masking the underlying cash burn and the lack of recurring, high-quality revenue streams from the core product portfolio.
This deferred revenue is essentially a liability that represents future performance obligations rather than a source of immediate liquidity. The rapid decline in this balance suggests that the company is exhausting its pre-paid collaboration funds, which may lead to a significant deterioration in the balance sheet's perceived strength in coming quarters.
Quick answers to the most common questions about buying GLPG stock.
As of 2025, Galapagos N.V. (GLPG) had total assets of $3.41B including $3.08B in current assets.
Galapagos N.V. (GLPG) carries total debt of $6.9M, offset by $3.00B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Galapagos N.V. (GLPG) has total shareholders' equity (book value) of $3.23B ($49.09 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Galapagos N.V. (GLPG) reported a current ratio of 20.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.